Pediatric Services
Patient Resources
For Professionals
Supporting Children's
Job Opportunities

Connect with Children's
Facebook Twitter YouTube RSS

  Print this page Email this page
     
Bookmark and Share
     

Pediatric Services

Contact the Aflac Cancer Center

Make an appointment.
Make a referral.
Make a donation.

Pediatric Physicians and Researchers

The Aflac Cancer Center and Blood Disorders Service of Children’s Healthcare of Atlanta continues to build a world-class program that includes clinical services at Children's at Egleston and Children's at Scottish Rite, as well as a close working collaboration with Emory University's Department of Pediatrics and the Emory Winship Cancer Institute. Our 40-plus physicians and researchers at the Aflac Cancer Center hold Emory University faculty appointments. Laboratory-based research, both basic and translational, is performed by our researchers at the Emory campus, in conjunction with vibrant clinical research activities at Children's.

  • Leadership
  • Blood and marrow transplant
  • Hematology
  • Cancer survivorship
  • Oncology
  •  

  • Neuro-oncology
  • Neuropsychology
  • Research/Innovative therapy
  • Basic and translational researchers
  • Leadership 

    • William G. Woods, M.D.
      Professor, Director and Daniel P. Amos Children's Chair for the Aflac Cancer Center and Blood Disorders Service, Dr. Woods is a distinguished physician and research scientist who leads some of the country's most admired pediatric hematology/oncology physicians.
    • Bradley George, M.D.
      Medical Director, Aflac Cancer Center of Children's at Scottish Rite
      Assistant Professor of Pediatrics
    • Thomas A. Olson, M.D.
      Medical Director, Aflac Cancer Center of Children's at Egleston

    Return to top

    Blood and Marrow Transplant (BMT)

    • Ann E. Haight, M.D.
      Director, BMT Program
      Assistant Professor of Pediatrics
      Research interests: BMT in sickle cell disease and other non-malignant disease; supportive care in BMT and infections in the immunocompromised host; clinical research ethics 
    • Kuang-Yueh (KY) Chiang, M.D., Ph.D.
      Associate Professor of Pediatrics
      Research interests: Clinical trials in BMT, stem cell biology and growth factor mobilization
    • John T. Horan, M.D., M.P.H.
      Assistant Professor of Pediatrics
      Research interests: Non-myeloablative transplant for sickle cell disease; graft versus host disease and outcomes research
    • Leslie S. Kean, M.D., Ph.D.
      Assistant Professor of Pediatrics
      Research interests: Transplant immunology with a special interest in immune tolerance-induction after non-myeloablative transplant 

    Return to top

    Hematology 

    • Peter A. Lane, M.D.
      Director, Hematology Disease Program
      Aflac Field Force Children’s Chair for Sickle Cell Disease
      Research interests: Newborn screening, health outcomes and clinical trials in sickle cell disease

    General Hematology

    • Carolyn M. Bennett, M.D.
      Assistant Professor of Pediatrics
      Research interests: Bone marrow failure syndromes, hemostasis and thrombosis 
    • Jeanne M. Boudreaux, M.D.
      Clinical Assistant Professor of Pediatrics
      Research interests: Bone marrow failure syndromes, hemolytic anemias and white cell disorders
    • Michael A. Briones, D.O.
      Program Director, Aflac Cancer Center Fellowship Program
      Assistant Professor of Pediatrics
      Research interests: General hematology and histiocytosis
    • Jeanne E. Hendrickson, M.D.
      Assistant Professor of Pediatrics
      Research interests: Pathology and transfusion medicine
    • Cassandra D. Josephson, M.D.
      Assistant Director, Children’s Blood Banks and Transfusion Services
      Assistant Professor of Pathology
      Research interests: Clinical transfusion medicine and blood safety in hemophilia, sickle cell disease, neonatology and open heart surgery
    • Marianne E. McPherson, M.D., M.Sc. 
      Assistant Professor of Pediatrics 
      Research interests: Sickle cell disease and hemoglobinopathies, specifically transfusion therapy for these disorders and reversal of chronic organ damage

    Hemophilia and Thrombosis

    • Carolyn M. Bennett, M.D., M.S.C.R.
      Assistant Professor of Pediatrics
      Research interests: Platelet disorder including immune thrombocytopenic purpura (ITP)
    • Jeanne M. Boudreaux, M.D.
      Assistant Professor of Pediatrics
      Research interests: Congenital platelet disorders
    • Michael A. Briones, D.O.
      Program Director, Aflac Cancer Center Fellowship Program
      Assistant Professor of Pediatrics
      Research interests: Central lines and thrombosis; clinical trials in thrombosis
    • Amy L. Dunn, M.D.
      Assistant Professor of Pediatrics
      Research interests: Joint disease in hemophilia; clinical trials in hemophilia and women with bleeding disorders
    • Jeanne E. Hendrickson, M.D.
      Assistant Professor of Pediatrics
      Research interests: Pathology and transfusion medicine
    • Shawn M. Jobe, M.D., Ph.D.
      Assistant Professor of Pediatrics
      Research interests: Platelet physiology
    • Cassandra D. Josephson, M.D.
      Assistant Director, Children’s Blood Banks and Transfusion Services
      Assistant Professor of Pathology
      Research interests: Clinical transfusion medicine and blood safety in hemophilia, sickle cell disease, neonatology and open heart surgery
    • Christine L. Kempton, M.D. M.Sc.
      Assistant Professor of Pediatrics
      Research interests: Clinical trials in hemophilia with an emphasis on inhibitors 
    • Shannon L. Meeks, M.D.
      Assistant Professor of Pediatrics
      Research interests: Factor VIII inhibitors; hemophilia; mild bleeding disorders

    Sickle Cell Disease

    • Jeanne M. Boudreaux, M.D.
      Assistant Professor of Pediatrics
      Research interests: Clinical trials in thalassemia
    • R. Clark Brown, M.D., Ph.D.
      Assistant Professor of Pediatrics
      Research interests: Targeted therapies for thalassemia and sickle cell disease
    • Iris D. Buchanan, M.D., M.Sc.
      Associate Professor of Pediatrics
      Research interests: Sickle cell disease pain management and pulmonary disease
    • Carlton D. Dampier, M.D.
      Professor of Pediatrics
      Research interests: Clinical trials in sickle cell disease; measurement science of patient and parent-reported outcomes, symptom management in sickle cell disease, particularly pain
    • Beatrice E. Gee, M.D.
      Director, Hematology and Sickle Cell Disease Program at Children's at Hughes Spalding 
      Assistant Professor of Pediatrics
      Research interests: Vascular pathophysiology that contributes to sickle cell disease complications and red blood cell membrane proteins
    • Anne G. James-Herry, M.D.
      Assistant Professor of Pediatrics
      Research interests: Clinical trials in sickle cell disease; comprehensive sickle cell pulmonary and pain clinics
    • Peter A. Lane, M.D.
      Director, Hematology and Sickle Cell Disease Program
      Professor of Pediatrics
      Research interests: Newborn screening, health outcomes and clinical trials in sickle cell disease
    • Marianne E. McPherson, M.D., M.Sc.
      Clinical Instructor
      Research interests: Sickle cell disease and hemoglobinopathies, specifically transfusion therapy for these disorders and reversal of chronic organ damage
    • Tamara N. New, M.D.
      Research interests: Clinical trials in sickle cell disease
    • Ifeyinwa (Ify) Osunkwo, M.D., M.P.H.
      Assistant Professor of Pediatrics
      Research interests: Clinical trials in sickle cell disease; chronic transfusion and hydroxyurea for the treatment of complications of sickle cell disease; and blood and marrow transplant for sickle cell disease
    • Yih-Ming Yang, M.D.
      Professor of Pediatrics
      Research interests: Clinical trials in sickle cell disease, newborn screening for hemoglobinopathies and strategies to raise fetal hemoglobin

    Fellows

    Return to top

    Childhood Cancer Survivorship 

    • Lillian R. Meacham, M.D.
      Director, Childhood Cancer Survivorship Program
      The Kathelen V. Amos Children's Chair for Cancer Survivorship
      Pediatric Endocrinologist
      Professor of Pediatrics
      Research interests: Childhood Cancer Survivor Study (CCSS) and other clinical trials in late effects and endocrine late effects in oncology patients
    • Ann C. Mertens, Ph.D.
      Director, Clinical Research
      Professor of Pediatrics
      Georgia Cancer Coalition Distinguished Scholar 
      Research interests: Childhood and adolescent cancer survivorship
    • Briana C. Patterson, M.D.
      Instructor of Pediatrics
      Research interests: Late effects of cancer therapy in brain tumor patients; endocrine problems following cancer treatment
    • Karen J. Wasilewski-Masker, M.D., M.Sc.
      Assistant Professor of Pediatrics
      Research interests: Outcomes/cancer survivor research; adolescent/young adult oncology; intervention studies in cancer late effects

    Return to top

    Oncology 

    Leukemia/Lymphoma 

    • D. John Bergsagel, M.D.
      Assistant Professor of Pediatrics
      Research interests: Clinical trials in leukemia and lymphoma
    • Todd M. Cooper, D.O.
      Director, Leukemia/Lymphoma Innovative Therapy Program
      Assistant Professor of Pediatrics
      Research interests: Clinical trials within COG in myeloid leukemia and development of novel therapies for children with relapsed leukemia
    • Frank G. Keller, M.D.
      Associate Professor of Pediatrics
      Research interests: PI of COG’s Hodgkin’s lymphoma trial; clinical trials in Hodgkin's disease, NHL and leukemia
    • Glen Lew, M.D.
      Associate Program Director, Aflac Cancer Center Fellowship Program
      Assistant Professor of Pediatrics
      Research interests: PI of COG’s trial for intermediate risk relapsed acute lymphocytic leukemia (ALL), etiology of childhood ALL and treatment of relapsed ALL
    • Tanya C. Watt, M.D., M.Sc.
      Assistant Professor of Pediatrics
      Research interests: Racial variation within AML; developing new therapies for relapsed leukemia
    • William G. Woods, M.D.
      Professor and Program Director
      Associate Chair of COG for Scientific Affairs; member of the COG Scientific Council and Executive Committees
      Research interests: Clinical trials within COG in myeloid leukemia

    Solid Tumors

    • Bradley A. George, M.D.
      Clinical Director, Aflac Cancer Center of Children's at Scottish Rite
      Assistant Professor of Pediatrics 
      Research interests: Clinical trials in sarcomas, neuroblastomas and other solid tumors
    • Kelly Goldsmith, M.D.
      Assistant Professor of Pediatrics
      Research interests: Clinical trials in neuroblastoma, Wilms tumor and other renal tumors of childhood
    • Howard M. Katzenstein, M.D.
      Director, Clinical Research and Innovative Therapy Program
      The Carter Samuel Martin Children's Chair for Innovative Therapy
      Associate Professor of Pediatrics
      Research interests: Principal Investigator (PI) of Children’s Oncology Group’s (COG) heptoblastoma trial; innovative therapy in liver tumors, neuroblastoma and solid tumors
    • Thomas A. Olson, M.D.
      Clinical Director, Aflac Cancer Center of Children’s at Egleston
      Associate Professor of Pediatrics
      Research interests: Chair, COG’s Germ Cell Subcommittee; clinical trials in germ cell tumors, retinoblastoma and bone tumors
    • Louis B. Rapkin, M.D.
      Assistant Professor of Pediatrics
      Research interests: Clinical trials in solid tumors; development of educational curriculum for house staff and fellows

    Return to top

    Neuro-Oncology 

    • Tobey J. MacDonald, M.D.
      Director, Pediatric Neuro-oncology Program
      Associate Professor of Pediatrics
      Research interests: Basic and translational research of childhood brain tumors with primary research focus on the role of platelet-derived growth factor receptor (PDGFR) signaling in medulloblastoma   
    • Dolly Aguilera, M.D.
      Assistant Professor of Pediatrics
      Research interests: Development of phase I and II clinical trials for children with recurrent brain tumors
    • Anna J. Janss, M.D., Ph.D.
      Associate Professor of Pediatrics
      Georgia Cancer Coalition Distinguished Scholar 
      Research interests: Phase I clinical trials (through the COG) and innovative therapeutics for brain tumors
    • Claire M. Mazewski, M.D.
      Associate Professor of Pediatrics
      Research interests: PI of COG high-risk medullo trial for young children; clinical trials, innovative therapeutics and late effects studies for children with brain tumors

    Return to top

    Neuropsychology 

    Return to top

    Research/Innovative Therapy 

    • Howard M. Katzenstein, M.D.
      Director, Clinical Research and Innovative Therapy Program
      The Carter Samuel Martin Children's Chair for Innovative Therapy
      Associate Professor of Pediatrics
      Research interests: PI of COG heptoblastoma trial; liver tumors, neuroblastoma, solid tumors and innovative therapies
    • Todd M. Cooper, D.O.
      Director, Leukemia/Lymphoma Innovative Therapy Program
      Assistant Professor of Pediatrics
      Research interests: Clinical trials within COG in myeloid leukemia and development of novel therapies for children with relapsed leukemia

    Return to top

    Basic and Translational Researchers 

    • David R. Archer, Ph.D.
      Assistant Professor of Pediatrics
      Research interests: Hematopoietic stem cell transplant for genetic disease, particularly sickle cell disease, and use of stem cells in regenerative medicine
    • Kevin D. Bunting, Ph.D.
      Associate Professor of Pediatrics
      Research interests: Laboratory focused studies on normal cytokine signaling in hematopoiesis and dysregulated signaling associated with leukemogenesis
    • Robert C. Castellino, M.D.
      Assistant Professor of Pediatrics
      Research interests: Pediatric neuro-oncology, cell signalling in neuronal development, drug development
    • Christopher B. Doering, Ph.D.
      Assistant Professor of Pediatrics
      Research interests: Development of modified blood coagulation factors and implementation in gene transfer-based therapies
    • Amy L. Dunn, M.D.
      Research interests: Basic mechanisms of hemophilic arthropathy
    • Jacques Galipeau, M.D.
      Research interests: Tumor immunology and biological and cellular therapies for autoimmune and alloimmune disorders; pediatric biopharmaceutical strategies for catastrophic diseases with unmet medical needs
      Professor of Pediatrics
    • Kelly Goldsmith, M.D.
      Assistant Professor of Pediatrics
      Research interests: Clinical trials in neuroblastoma, Wilms tumor and other renal tumors of childhood
    • Lubing Gu, M.D.
      Assistant Professor of Pediatrics
      Research interests: Molecular mechanisms of drug resistance in childhood cancer and leukemia
    • Shawn M. Jobe, M.D., Ph.D.
      Assistant Professor of Pediatrics
      Research interests: Platelet physiology
    • Leslie S. Kean, M.D., Ph.D.
      Assistant Professor of Pediatrics
      Research interests: Transplant immunology with a special interest in immune tolerance-induction after non-myeloablative transplant
    • John Sherman (Pete) Lollar III, M.D.
      Director, Hemostasis Research
      Chair, Hemophilia of Georgia Inc.
      Research interests: Development of novel recombinant factor VIII (fVIII) molecules for use in preventing and treating hemophilia patients with inhibitors; basic research in biosynthesis and expression of fVIII
    • Tobey J. MacDonald, M.D.
      Director, Pediatric Neuro-oncology Program
      Associate Professor of Pediatrics
      Research interests: Basic and translational research of childhood brain tumors with primary research focus on the role of platelet-derived growth factor receptor (PDGFR) signaling in medulloblastoma  
    • Shannon L. Meeks, M.D.
      Instructor of Pediatrics
      Research interests: Factor VIII inhibitors; hemophilia; mild bleeding disorders
    • Solomon F. Ofori-Acquah, Ph.D.
      Assistant Professor of Pediatrics
      Research interests: Endothelial barrier function involving leukocyte recruitment and angiogenesis, particularly as it relates to sickle cell disease; gene regulation in haematopoiesis and sickle cell disease
    • H. Trent Spencer, Ph.D.
      Director, Gene Therapy Program
      Assistant Professor of Pediatrics
      Georgia Cancer Coalition Distinguished Scholar 
      Research interests: Gene therapy for treatment of cancer and inherited disease via recombinant retroviral vectors and drug resistance immunotherapy
    • Zhengqi Wang, Ph.D.
      Assistant Professor of Pediatrics 
      Research interests: Study of STAT5 and its function in signaling mechanisms in leukemogenesis; hematopoietic stem cell biology and transplant
    • Muxiang Zhou, M.D.
      Associate Professor of Pediatrics
      Research interests: Signaling pathways and regulators of apoptosis as they relate to drug resistance in ALL

    Return to top

     

    Physicians and researchers at the Aflac Cancer Center are faculty members at Emory University School of Medicine.